{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:05:27Z","timestamp":1790301927030,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.cardfail.2011.08.005","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T21:09:26Z","timestamp":1315688966000},"page":"973-981","source":"Crossref","is-referenced-by-count":86,"title":["A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction"],"prefix":"10.1016","volume":"17","author":[{"given":"James E.","family":"Udelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bilsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Hauptman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignatius","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin A.","family":"Konstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2011.08.005_bib1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/08860229809045175","article-title":"Pathogenesis of sodium and water retention in cardiac failure","volume":"20","author":"Schrier","year":"1998","journal-title":"Renal Failure"},{"key":"10.1016\/j.cardfail.2011.08.005_bib2","series-title":"Diuretic Agents \u2013 Clinical Physiology and Pharmacology","first-page":"571","article-title":"Potassium disturbances associated with the use of diuretics","author":"Palmer","year":"1997"},{"key":"10.1016\/j.cardfail.2011.08.005_bib3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/bmj.282.6274.1432","article-title":"Synergistic actions of metolazone with loop diuretics","volume":"812","author":"Ghose","year":"1981","journal-title":"Br Med J"},{"key":"10.1016\/j.cardfail.2011.08.005_bib4","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/hc4501.099313","article-title":"Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure","volume":"104","author":"Udelson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2011.08.005_bib5","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin receptor blockade in patients with congestive heart failure: results from a randomized, double-blind study","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2011.08.005_bib6","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2011.08.005_bib7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2011.08.005_bib8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2011.08.005_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1071-9164(99)91339-8","article-title":"Vasopressin: a therapeutic target in congestive heart failure?","volume":"5","author":"Goldsmith","year":"1999","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2011.08.005_bib10","first-page":"H261","article-title":"Direct cardiac effects of vasopressin: role of V1- and V2- vasopressinergic receptors","volume":"255","author":"Walker","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib11","first-page":"F321","article-title":"Osmotic and nonosmotic control of vasopressin release","volume":"236","author":"Schrier","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.RES.69.1.239","article-title":"Vasopressin increases cytosolic free calcium in neonatal rat cardiocyte: evidence for V1 receptor subtype","volume":"69","author":"Xu","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2011.08.005_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0008-6363(97)00324-6","article-title":"Effects of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte","volume":"38","author":"Tahara","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2011.08.005_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1006980517557","article-title":"Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor","volume":"195","author":"Fukuzawa","year":"1999","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cardfail.2011.08.005_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(82)90576-9","article-title":"Antidiuretic hormone in congestive heart failure","volume":"72","author":"Riegger","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.cardfail.2011.08.005_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1253\/jcj.32.745","article-title":"Plasma ADH level in patients with chronic congestive heart failure","volume":"32","author":"Yamane","year":"1968","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.cardfail.2011.08.005_bib17","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(83)80040-0","article-title":"Increased plasma arginine vasopressin levels in patients with congestive heart failure","volume":"1","author":"Goldsmith","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib18","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2011.08.005_bib19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0735-1097(86)80333-3","article-title":"Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous system","volume":"7","author":"Creager","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0735-1097(94)90001-9","article-title":"Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril","volume":"24","author":"Rouleau","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib21","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2011.08.005_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2011.08.005_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0735-1097(03)00765-4","article-title":"Diuretic\u00a0use, progressive heart failure, and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"42","author":"Domanski","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2011.08.005_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","article-title":"Renal function, neurohormonal activation and survival in patients with chronic heart failure","volume":"102","author":"Hillege","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2011.08.005_bib26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0002-9149(00)00705-0","article-title":"Correlates and impact on outcome of worsening renal function in patients 65 years of age with heart failure","volume":"85","author":"Krumholz","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib27","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","article-title":"Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure","volume":"290","author":"Costello-Boerrigter","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-9149(94)90815-X","article-title":"Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy","volume":"73","author":"Grinstead","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/hrt.72.6.534","article-title":"The apparent paradox of neurohormonal axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention","volume":"72","author":"Guazzi","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.cardfail.2011.08.005_bib30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0735-1097(01)01479-6","article-title":"Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure","volume":"38","author":"Marenzi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib31","first-page":"F460","article-title":"Chronic effects of vasopressin on plasma renin activity in sodium-restricted dogs","volume":"250","author":"Merrill","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2011.08.005_bib32","first-page":"F46","article-title":"Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney","volume":"279","author":"Ecelbarger","year":"2000","journal-title":"Am J Physiol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916411010529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916411010529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T13:30:08Z","timestamp":1741613408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916411010529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1071916411010529"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2011.08.005","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}